Facial Filler for Temporal Hollowing

Recruiting in Palo Alto (17 mi)

+14 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Galderma R&D

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.

Eligibility Criteria

This trial is for men and women over the age of 22 who want to treat temple hollowing without a history of facial surgery, migraines, or allergies to hyaluronic acid gels or local anesthetics. Pregnant or breastfeeding individuals cannot participate.

Inclusion Criteria

I plan to get treatment for temple hollowing.

I am a man or a woman not pregnant or breastfeeding, aged 22 or older.

Exclusion Criteria

I often have severe headaches or migraines.

I am allergic to some injectable skin treatments or certain bacterial proteins.

I have had facial surgery that might affect the study's safety or results.

See 2 more

Treatment Details

Interventions

Restylane Contour (Dermal Filler)

Trial OverviewThe study tests Restylane Contour's effectiveness and safety in treating temple hollowing. Participants are randomly assigned to receive the treatment or no treatment, with evaluators blinded to which group they're in.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: TreatmentExperimental Treatment1 Intervention

Group II: ControlActive Control1 Intervention